These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22270052)

  • 21. Long-term survival analysis in metastatic melanoma: serum S100B is an independent prognostic marker and superior to LDH.
    Egberts F; Pollex A; Egberts JH; Kaehler KC; Weichenthal M; Hauschild A
    Onkologie; 2008 Jul; 31(7):380-4. PubMed ID: 18596385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma.
    Berger AC; Fierro M; Kairys JC; Berd D; Sato T; Andrel J; Hyslop T; Mastrangelo MJ
    J Surg Oncol; 2012 Jan; 105(1):15-20. PubMed ID: 21815149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors for survival of patients treated systemically for disseminated melanoma.
    Eton O; Legha SS; Moon TE; Buzaid AC; Papadopoulos NE; Plager C; Burgess AM; Bedikian AY; Ring S; Dong Q; Glassman AB; Balch CM; Benjamin RS
    J Clin Oncol; 1998 Mar; 16(3):1103-11. PubMed ID: 9508197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma.
    McMasters KM; Edwards MJ; Ross MI; Reintgen DS; Martin RC; Urist MM; Noyes RD; Sussman JJ; Stromberg AJ; Scoggins CR
    Ann Surg; 2010 Sep; 252(3):460-5; discussion 465-6. PubMed ID: 20739846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged survival after complete resection of metastases from intraocular melanoma.
    Hsueh EC; Essner R; Foshag LJ; Ye X; Wang HJ; Morton DL
    Cancer; 2004 Jan; 100(1):122-9. PubMed ID: 14692032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolated limb infusion for malignant melanoma: predictors of response and outcome.
    Barbour AP; Thomas J; Suffolk J; Beller E; Smithers BM
    Ann Surg Oncol; 2009 Dec; 16(12):3463-72. PubMed ID: 19830498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
    Eigentler TK; Buettner PG; Leiter U; Garbe C;
    J Clin Oncol; 2004 Nov; 22(21):4376-83. PubMed ID: 15514379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second primary melanomas: incidence and outcome.
    Bower MR; Scoggins CR; Martin RC; Mays MP; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Noyes RD; Sussman JJ; Hagendoorn LJ; Stromberg AJ; McMasters K
    Am Surg; 2010 Jul; 76(7):675-81. PubMed ID: 20698369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age and gender are significant independent predictors of survival in primary cutaneous melanoma.
    Lasithiotakis K; Leiter U; Meier F; Eigentler T; Metzler G; Moehrle M; Breuninger H; Garbe C
    Cancer; 2008 Apr; 112(8):1795-804. PubMed ID: 18306371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Independent prognostic importance of vascular invasion in nodular melanomas.
    Straume O; Akslen LA
    Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A long-term analysis of 620 patients with malignant melanoma at a major referral center.
    Averbook BJ; Russo LJ; Mansour EG
    Surgery; 1998 Oct; 124(4):746-55; discussion 755-6. PubMed ID: 9780997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex is an independent prognostic indicator for survival and relapse/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European organisation for research and treatment of cancer randomized controlled trials.
    Joosse A; Collette S; Suciu S; Nijsten T; Patel PM; Keilholz U; Eggermont AM; Coebergh JW; de Vries E
    J Clin Oncol; 2013 Jun; 31(18):2337-46. PubMed ID: 23690423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
    Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
    Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
    Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
    Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of hypoxic radiosensitizer sodium glycididazole on long-term result of radiotherapy for nasopharyngeal carcinoma].
    Liu MZ; He LR; Lu TX; Chen YY; Hu YH; Cui NJ; Xu GZ; Gao L; Xiao GL; Zhang SW; Cai Y; Li DM; Chen LH; Wang FY; Sun Q; Zhu L; Sheng G; Gao HJ; Bao YH
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):932-7. PubMed ID: 17533747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sarcopenia as a prognostic factor among patients with stage III melanoma.
    Sabel MS; Lee J; Cai S; Englesbe MJ; Holcombe S; Wang S
    Ann Surg Oncol; 2011 Dec; 18(13):3579-85. PubMed ID: 21822551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma.
    Kunte C; Geimer T; Baumert J; Konz B; Volkenandt M; Flaig M; Ruzicka T; Berking C; Schmid-Wendtner MH
    Melanoma Res; 2010 Aug; 20(4):330-7. PubMed ID: 20526218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
    Roka F; Kittler H; Cauzig P; Hoeller C; Hinterhuber G; Wolff K; Pehamberger H; Diem E
    Br J Cancer; 2005 Feb; 92(4):662-7. PubMed ID: 15700039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.